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Goodpasture's syndrome is characterized by pulmonary associated 
with renal abnormalities and a group of systemic diseases share 
immunopathogenic mechanisms which is an autoimmune anti-
glomerular basement membrane disease. Pulmonary renal syndrome 
is rather common in the western countries, but rare in Japan. The 
present two cases showed clinical and pathological features of rapidly 
progressive glomerulonephritis complicated with massive pulmonary 
hemorrhage. Most of the hemorrhage appeared acute with intact red 
blood cells in alveolar spaces, and also had variable numbers of 
hemosiderin-laden macrophages as an evidence of old hemorrhage. In 
one case of Goodpasture's syndrome, linear deposits of IgG were 
demonstrated in alveolar walls, glomerular capillary, Bowman's 
capsular basement membrane, and tubules of kidneys. These evi-
dences indicate the present two cases to be the so-called Goodpas-
ture's syndrome.
pathogenetic definition in the disease entity known as 
Goodpasture's syndrome. Immunohistochemical studies 
demonstrated a linear deposition of IgG along the glom-
erular basement membrane as well as the alveolar basement 
membrane (Beechler et al., 1980; Beirne et al., 1968; 
Hogan et al., 1978; Koffler et al., 1969; Kondo et al., 1986; 
Lombard and Colby, 1989; Sturgill and Westervelt, 1965). 
 The present paper describes two autopsy cases of the 
so-called Goodpasture's syndrome as intrapulmonary hem-
orrhage (Fig. 1) and glomerulonephritis (Fig. 2).
Introduction 
The association of glomerulonephritis and hemorrhagic 
pneumonitis was first described by Goodpasture in 1919. 
Goodpasture's syndrome is typically associated with a 
dramatic course characterized by rapid loss of renal func-
tion and asphyxia, which is traditionally considered to be a 
singles-phase illness characterized by the loss of renal 
function, death from lung hemorrhage, or rarely, complete 
recovery. Goodpasture's syndrome, characterized clinically 
as glomerulonephritis associated with pulmonary hemor-
rhages, can be more narrowly defined immunopatho-
logically as antibody against glomerular basement 
membrane and antialveolar basement membrane disease. It 
is generally accepted that antibasement membrane anti-
bodies are directly involved in the initiation and the devel-
opment of glomerulonephritis and pulmonary hemorrhage. 
The clinical features of intrapulmonary hemorrhage with 
hemoptysis, anemia, and radiologic evidence of lung infil-
trates associated with glomerulonephritis are linked by
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Fig. 1. On the cut surface of the lung, hemorrhages, pneumonia, 
and fibrosis were observed.
Fig. 2. On the cut surface of the kidney, finely granular nephros-
clerosis was seen
Report of Cases 
Case 1 A 54-year-old Japanese man presented with cough, 
fever, headache, and hemoptysis Chest roentgenograms 
showed diffuse bilateral alveolar infiltrates Laboratory 
data showed blood urea nitrogen level of 172 2mg/dl 
(normal range, 8-20mg/dl), creatinine clearance level of 
9 7mu/dl (normal range, 0 8-1 4mu/dl) At that time, the 
liver function tests revealed glutamic oxalacetic trans-
aminase level of 1880mu/ml (normal range, 5-28mu/ml), 
glutamic pyruvic transaminase level of 1750mu/ml (normal 
range 0-24mu/ml), and leucine aminopeptidase level of 
2430mu/ml (normal range, 235-440mu/ml) The patient 
died one week after admission The immediate cause of 
death was renal failure or exacerbation of respiratory fail-
ure An autopsy was performed 26 hours after death 
  Postmortem examination revealed major abnormalities in 
the lungs, kidneys, and liver The lungs were enlarged, 
relatively hardened and soiled Their surface were mottled 
with red and purplish hemorrhages On the cut surface 
there were edema, as well as red and brown areas of recent 
and old hemorrhages Light microscopically, there was 
massive hemorrhage in the alveolar spaces (Fig 3) There 
were areas of recent intra-alveolar hemorrhage and many 
gatherings of hemosiderin-laden macrophages (Fig 4) 
Diffuse fibrosis of the alveolar walls was prominent, and 
occasional small nodules of dense fibrous tissue were 
present Fibrinogen was present in alveolar spaces On 
gross examination the kidneys were soft and enlarged, and 
many foci of petechial hemorrhage were observed over the 
subcapsular surface and the cut surfaces Light microscop-
ically, there were acute hemorrhage and thrombus forma-
tion in the glomeruli (Fig 5), and hemorrhagic cast 
formation in the collecting tubules (Fig 6) 
  Case 2 A 65-year-old Japanese man presented with 
cough, and pain of joint Chest roentgenograms showed
Fig. 3. Hemorrhagic interstitial pneumonia and Massive hemor-
rhage are found in alveolar spaces Mild to moderate edema and 
fibrosis of alveolar walls with moderate inflammatory cell infil-
tration are observed Hematoxylin and eosin stain, original magni-
fication x 20
Fig. 4. There are extensive intra-alveolar hemorrhage and abun 
dant hemosiderin-laden macrophages within alveoli Hematoxylin 
and eosin stain, original magnification x 100
Fig. 5. Hemorrhage and thrombus formation are seen in the 
glomeruli Modified Mallory's stain for collagen, original magni-
fication x 100
Fig. 6. Hemorrhagic cast formation and necrosis are detected in 
the tubules of Kidney Hematoxylin and eosin stain, original 
magnification x 100
abnormal shadow in the left lung Laboratory data showed 
blood urea nitrogen level of 168mg/dl (normal 
range, 8-20mg/dl) At that time, the liver function tests for 
glutamic oxalacetic transaminase level of 114mu/ml (nor-
mal range,5-28mu/ml), glutamic pyruvic transaminase level 
of 126mu/ml (normal range,0-24mu/ml), and leucine ami-
nopeptidase level of 1076mu/ml (normal range,235-440 
mu/ml) Gamma G globulin (IgG) titer was 1607 which 
was marker immunoglobulin of Goodpasture's syndrome 
On the other hand, other immunoglobulins were demon-
strated such as IgA 304, IgG 89, and IgE 1210 The patient 
died ten days after admission The main cause of death was 
respiratory failure An autopsy was performed one hour 
thirty minutes after death 
  Postmortem examination revealed major abnormalities in 
the lungs, and in the kidneys On the cut surface of the 
lungs were edema, as well as red and brown areas of recent 
and old hemorrhages These lungs had acute and chronic 
pneumonia, fibrosis, emphysema and bulla formation 
Light microscopically, there was massive hemorrhage in 
the alveolar spaces There were areas of recent intra-
alveolar hemorrhage and many gatherings of hemosiderin-
laden macrophages Diffuse fibrosis of alveolar walls was 
prominent Alveolar walls and intraalveolar fibrin-like 
materials were stained with anti-IgG (Fig 7) On gross 
examination the kidneys had fine granular nephrosclerosis 
Light microscopically, there were hemorrhagic cast forma-
tion and necrosis of renal tubles Extracapillary prolif-
erative lesions showed circumferential cellular crescent 
associated with varying degrees of capillary tufts Glom-
erular capillaries, Bowman's capsular basement membrane 
and tubules of kidneys were stained by anti-IgG (Fig 8)
Fig. 7. Lung tissue demonstrating positive immunoperoxidase for 
linear deposits of IgG antibody on alveolar walls Immunoreaction 
for IgG x 400
Fig. 8. Renal tissue revealing the linear immunoperoxidase 
staining for IgG antibody on Bowman's capsular basement mem 
brane and tubules of kidneys Immunoreaction for IgG x 400
Discussion 
In 1919, Goodpasture described the coexistence of pulmo-
nary hemorrhage and glomerulonephritis 6 weeks after 
influenza in a young man (Goodpasture, 1919) The term 
Goodpasture's syndrome was coined by Stanton and Tange 
in 1958 to describe cases characterized by the coexistence 
of these manifestations (Saus et al, 1988) The autoan-
tibodies were distributed along the alveolar septa basement 
membranes and the glomerular basement membranes in a 
linear manner, reflecting reactivity with specific glomerular 
basement membrane antigens The cause of the condition is 
unknown It has been suggested that it may be related to an 
autoimmune reaction The syndrome is now defined as an 
autoimmune disorder consisting of the triad of glomerulo-
nephritis, lung hemorrhage, antibody against glomerular 
basement membrane antibody formation, and it includes a 
broad spectum of clinical features, resulting in injury to
tissues that is clinically manifeasted by acute glomerulo-
nephritis (Beechler et al., 1980; Beirne et al., 1968; Gold-
stein et al., 1986; Hogan et al., 1978; Koffler et al., 1969; 
Kondo et al., 1986; Stugill and Zwestervelt, 1965). The 
present cases showed clinical and pathological features of 
rapidly progressive glomerulonephritis complicated with 
massive pulmonary hemorrhage. These evidences indicate 
the present cases to be a disease of the so-called Goodpas-
ture's syndrome. 
 The mechanism underlying the association of progres-
sive glomerulonephritis and alveolar hemorrhage in Good-
pasture's syndrome has been clarified recently by the 
identification of antibody against glomerular basement 
membrane antibodies in glomerular and alveolar septa. In 
the past decade, many investigators have focused on the 
molecular origin and nature of the Goodpasture's antigen 
of renal glomerular basement membrane that binds the 
Goodpasture's antibodies. This information is of funda-
mental importance in delineating the molecular basis of the 
syndrome and in designing diagnostic tests. Basement 
membranes are complex extracellular structures containing 
at least four types of protein components. These include: (1) 
a collagen component, now referred to as type IV procol-
lagen (Butkowski et al., 1985, 1987; Saus et al., 1988; 
Wieslander et al., 1984, 1985); (ii) a glycoprotein compo-
nent, now known as lamine (Beirne et al., 1968; Ohno et 
al., 1986; Timpl et al., 1979); (iii) proteoglycans, which 
include heparan sulfate and chondroitin sulfate (Kanway 
and Farquhar, 1979; Kanway et al., 1984); and (iv) entac-
tin, a sulfated glycoprotein (Bender et al., 1981). The 
mechanisms underlying the development of antibody 
against glomerular basement membrane antibodies remain 
to be studied. 
 Ramkin and Matthay (1982) proposed etiologies and 
immunopathogenic mechanisms of a group of systemic 
diseases which share pulmonary and renal abnormalities. 
They also discussed the following disease: (1) Goodpas-
ture's syndrome; (ii) two connective tissue (collagen vas-
cular) diseases, systemic lupus erytheromatosus and 
progressive systemic sclerosis (scieroderma); and (iii) three 
granulomatous vasculidities, Wegener's granulomatosis, 
lymphomatoid granulomatosis, and Churg-Strauss syn-
drome. Albelda and co-workers (1985) stated on diffuse 
pulmonary hemorrhage and presented a classification 
scheme depicted as a Venn diagram formed by four over-
lapping circles such as (1) pulmonary hemorrhage, (2) 
renal disease, (3) immune complex disease, and (4) anti-
glomerular basement membrane disease. This scheme 
results divided diffuse pulmonary hemorrhage into six 
categories (Group 1) pulmonary hemorrhage associated 
with glomerulonephritis and antiglomerular basement 
membrane antibody; (Group 2) pulmonary hemorrhage 
associated with renal disease without demonstrable immu-
nologic abnormalities; (Group 3) pulmonary hemorrhage 
associated with glomerulonephritis and immune complex
disease; (Group 4) pulmonary hemorrhage and immune 
complex disease without renal disease; (Group 5) pulmo-
nary hemorrhege associated with antiglomerular basement 
membrane antibody without renal disease; (Group 6) pul-
monary hemorrhage without demonstrable immunologic 
associations or renal disease. Categories 1, 2, and 3 groups 
contained diffuse pulmonary hemorrhage associated with 
renal disease and might be considered the generic term 
"Goodpasture's syndrome."
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